New Results

In silico and in vitro screening of FDA-approved drugs for potential repurposing against tuberculosis

Sridharan Brindha, Jagadish Chandrabose Sundaramurthi, Savariar Vincent, Devadasan Velmurugan, John Joel Gnanadoss
doi: https://doi.org/10.1101/228171

Article Information

doi 
https://doi.org/10.1101/228171
History 
  • December 3, 2017.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Sridharan Brindha1,
  2. Jagadish Chandrabose Sundaramurthi2,
  3. Savariar Vincent1,
  4. Devadasan Velmurugan3 and
  5. John Joel Gnanadoss1,*
  1. 1Loyola College, Nungambakkam, Chennai 600034, Tamil Nadu, India
  2. 2National Institute for Research in Tuberculosis (ICMR), Chetpet, Chennai 600031, Tamil Nadu, India
  3. 3CAS in Crystallography and Biophysics, University of Madras, Guindy Campus, Chennai – 600025, Tamil Nadu, India
  1. ↵* Corresponding Author: Dr. John Joel Gnanadoss Assistant Professor Department of Biotechnology Loyola College (University of Madras) Nungambakkam, Chennai – 600034 Tamil Nadu, India. Phone: 9840985870, E-mail: joelgna{at}gmail.com
Back to top
Posted December 03, 2017.
Download PDF
Email
In silico and in vitro screening of FDA-approved drugs for potential repurposing against tuberculosis
Sridharan Brindha, Jagadish Chandrabose Sundaramurthi, Savariar Vincent, Devadasan Velmurugan, John Joel Gnanadoss
bioRxiv 228171; doi: https://doi.org/10.1101/228171
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area